Clinical Trial: Marshall Vein Ethanol Infusion in Addition to Pulsed Electric Field Ablation Versus Pulsed Electric Field Ablation Alone for Paroxysmal Atrial Fibrillation

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07095959) titled 'Marshall Vein Ethanol Infusion in Addition to Pulsed Electric Field Ablation Versus Pulsed Electric Field Ablation Alone for Paroxysmal Atrial Fibrillation' on July 22.

Brief Summary: The Marvel-PAF trial is an investigator initiated, multi-center, open-label, randomized trial, which aims to compare the effectiveness of vein of Marshall in addition to pulmonary vein isolation using pulsed field ablation in the treatment of paroxysmal atrial fibrillation. The primary endpoint is any atrial arrhythmias lasting >=30s without AAD during 12 months after procedure excluding the 2-months blanking period.

Study Start Date: Aug. 10

Study Ty...